Kerry Ettridge
Overview
Explore the profile of Kerry Ettridge including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
227
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhu X, Miller C, Roberts R, Ettridge K
Health Promot J Austr
. 2025 Feb;
36(2):e70004.
PMID: 39980376
Issue Addressed: Effective interventions to reduce energy drink (ED) consumption are needed. This study explored the effect of warning labels on intentions to reduce ED consumption, perceived label effectiveness and...
2.
Charlick M, Tiruye T, Ettridge K, OCallaghan M, Jay A, Beckmann K
BMC Urol
. 2025 Jan;
25(1):21.
PMID: 39891173
Background: Although sexual dysfunction is a common treatment side-effect affecting men's quality of life, many prostate cancer patients do not receive or seek out treatments for erectile dysfunction (ED). The...
3.
Miller C, Kay E, Dono J, Ettridge K
BMC Med
. 2024 Nov;
22(1):541.
PMID: 39558314
Background: Front-of-pack (FOP) warning labels have demonstrated effectiveness for reducing sugar-sweetened beverage (SSB) consumption and switching to water. However, an unintended consequence is that they may also increase switching to...
4.
Charlick M, Tiruye T, Ettridge K, OCallaghan M, Sara S, Jay A, et al.
Psychooncology
. 2024 Aug;
33(8):e9303.
PMID: 39138118
Objective: Despite available support, sexuality needs are the most frequently reported unmet need among men with prostate cancer, which may be due to low help-seeking rates. Using the Ecological Systems...
5.
Tiruye T, Hiwase M, Charlick M, OCallaghan M, Khalid A, Li M, et al.
Psychooncology
. 2024 Jul;
33(7):e6369.
PMID: 38960607
Objective: Prostate cancer can significantly impact mental wellbeing, creating uncertainty and morbidity. This study described patterns of psychotropic medication and mental health service use, as a proxy measure for mental...
6.
Tiruye T, OCallaghan M, Ettridge K, Moretti K, Jay A, Higgs B, et al.
BJUI Compass
. 2024 Jan;
5(1):109-120.
PMID: 38179028
Objectives: To describe real-world clinical and functional outcomes in an Australian cohort of men with localised prostate cancer according to treatment type and risk category. Subjects And Methods: Men diagnosed...
7.
Ziesing S, Ettridge K, Dono J, Luppino A, Miller C
Aust N Z J Public Health
. 2023 Sep;
47(5):100080.
PMID: 37739846
Objective: Reducing tobacco licences is one potential lever to reduce tobacco-related harms. A 15-fold increase in annual tobacco retailer licence fees in 2007 led to a 24% decline in the...
8.
Tiruye T, OCallaghan M, Ettridge K, Jay A, Santoro K, Moretti K, et al.
Prostate
. 2023 Feb;
83(7):678-687.
PMID: 36825533
Background: Active surveillance (AS) aims to reduce overtreatment and minimize the negative side effects of radical therapies (i.e., prostatectomy or radiotherapy) while preserving quality of life. However, a substantial proportion...
9.
Tiruye T, OCallaghan M, Moretti K, Jay A, Higgs B, Santoro K, et al.
BMC Urol
. 2022 Nov;
22(1):169.
PMID: 36335325
Background: The aim of this study was to describe changes in patient-reported functional outcome measures (PROMs) comparing pre-treatment and 12 months after radical prostatectomy (RP), external beam radiation therapy (EBRT),...
10.
Miller C, Dono J, Wright K, Pettigrew S, Wakefield M, Coveney J, et al.
Nutrients
. 2022 Oct;
14(19).
PMID: 36235825
Front-of-pack (FoP) warning labels are a viable policy option with the potential to inform consumer choice and assist in reducing sugar-sweetened beverage (SSB) consumption as part of a multi-faceted approach....